|
MK-2828 Clinical Trials
1 actively recruiting trial across 1 location
Chula Vista, California1 trial
Multiple Dose Study of MK-2828 in Participants With Type 2 Diabetes (MK-2828-003)
ProSciento Inc. ( Site 0004)
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.